HI HB1655 | 2014 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 15 2014 - 25% progression, died in chamber
Action: 2014-02-07 - Passed Second Reading as amended in HD 1 and referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and Representative(s) Tokioka, Yamane excused (2).
Text: Latest bill text (Amended) [HTML]
Status: Introduced on January 15 2014 - 25% progression, died in chamber
Action: 2014-02-07 - Passed Second Reading as amended in HD 1 and referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and Representative(s) Tokioka, Yamane excused (2).
Text: Latest bill text (Amended) [HTML]
Summary
Eliminates unearmarked general funds as a source of funds for the Hawaii Cancer Research Special Fund beginning on July 1, 2017. Effective July 1, 2525. (HB1655 HD1)
Title
Hawaii Cancer Research Special Fund; Funding ($)
Sponsors
| Rep. Isaac Choy [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2014-02-07 | House | Passed Second Reading as amended in HD 1 and referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and Representative(s) Tokioka, Yamane excused (2). |
| 2014-02-07 | House | Reported from HED (Stand. Com. Rep. No. 217-14) as amended in HD 1, recommending passage on Second Reading and referral to FIN. |
| 2014-01-30 | House | The committees on HED recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 9 Ayes: Representative(s) Choy, Ichiyama, Awana, Hanohano, Ohno, Say, Takumi, Matsumoto, Fale; Ayes with reservations: none; Noes: none; and 2 Excused: Representative(s) Aquino, Takai. |
| 2014-01-23 | House | Bill scheduled to be heard by HED on Thursday, 01-30-14 2:15PM in House conference room 309. |
| 2014-01-21 | House | Referred to HED, FIN, referral sheet 3 |
| 2014-01-15 | House | Introduced and Passed First Reading |
| 2014-01-13 | House | Prefiled |
Same As/Similar To
SB2554 (Same As) 2014-01-21 - Referred to HRE, WAM.
